Moberg Pharma
10,17
SEK
0 %
MOB
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
6 investorer følger denne virksomhed
0%
0%
-39,17%
+3,67%
-64,93%
-34,81%
-70,58%
-88,82%
-82,98%
Moberg Pharma is a Swedish pharmaceutical company focused on the commercialization of proprietary medicines based on proven substances. The company mainly works in nail fungus, where Moberg Pharma is developing a new external treatment. The company has agreements with commercial partners on site in Europe and Asia, among other places. The head office is in Bromma.
Læs mereMarkedsværdi
486,94 mio. SEK
Aktieomsætning
3,27 mio. SEK
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Finanskalender
11.2
2025
Årsrapport '24
13.5
2025
Delårsrapport Q1'25
22.5
2025
Generalforsamling '24
ViserAlle indholdstyper
Moberg Pharma reports topline data in the North American phase 3 study and will regain rights to MOB-015 in EU
Redeye: Moberg Pharma Q3’2024 - Launch in focus awaiting top line data
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools